Boston Trust Walden’s Axcelis ACLS Stock Holding History

Boston Trust Walden’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$44.7M	Sell	340,419 -18,837	-5%	-$2.41M	0.36%	97
2026 Q2	$68.1M	Sell	359,256 -19,269	-5%	-$2.86M	0.52%	66
2026 Q1	$35.2M	Sell	378,525 -49,211	-12%	-$4.36M	0.29%	126
2025 Q4	$34.4M	Sell	427,736 -32,551	-7%	-$2.73M	0.26%	140
2025 Q3	$44.9M	Sell	460,287 -385,624	-46%	-$31.1M	0.33%	121
2025 Q2	$59M	Buy	845,911 +19,579	+2%	+$1.12M	0.42%	91
2025 Q1	$41M	Buy	826,332 +6,216	+0.8%	+$393K	0.3%	132
2024 Q4	$57.3M	Buy	820,116 +313,689	+62%	+$26.1M	0.4%	89
2024 Q3	$53.1M	Buy	+506,427	New	+$59.2M	0.37%	107

Other funds holding ACLS

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

ARGA Investment Management Stamford, Connecticut $3.94B AUM 28.9% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

B. Metzler seel. Sohn & Co Frankfurt, Germany $11.5B AUM 29.17% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Boston Trust Walden's ACLS Position: Q3 2026 in Review

Boston Trust Walden reduced its Axcelis (ACLS) stake by 5.2% in Q3 2026, selling an estimated $2.41M and leaving 340,419 shares worth $44.7M. The position accounts for 0.36% of the portfolio, ranked #97.

Boston Trust Walden first reported a position in ACLS in Q3 2024 and has held it in 9 quarters since. The position peaked at $68.1M in Q2 2026. 100 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

Boston Trust Walden held 340,419 shares of Axcelis worth $44.7M as of Q3 2026.
Boston Trust Walden sold 18,837 Axcelis shares in Q3 2026, an estimated $2.41M.
Axcelis made up 0.36% of Boston Trust Walden's portfolio in Q3 2026, its #97 holding.
Boston Trust Walden first reported a position in Axcelis in Q3 2024 and has held it in 9 quarters since.
Boston Trust Walden's Axcelis position peaked at $68.1M in Q2 2026.
100 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.